Evaluation of the clinical Outcome of Beta Glucan & Nano ECF (Entro-Coccus Faecalis) in Children with ASD (Autism spectrum disorders)
Not Applicable
Completed
- Conditions
- Health Condition 1: F949- Childhood disorder of social functioning, unspecified
- Registration Number
- CTRI/2020/10/028322
- Lead Sponsor
- Medi Nippon Health Care Private Limited MD
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 17
Inclusion Criteria
1. Subjects aged less than 18 years
2. Both male and female
3. ASD criteria as per CARS (Childhood Autism Rating Scale) score
4. Parents willing to consent for their children for actively participating in the study
Exclusion Criteria
1. Subjects aged more than 18 years old
2. Any child with acute general illness or is on any antibiotic, anti-inflammatory, or antioxidant treatment for the last two weeks
3. Hyperallergic to any of the investigational products
4. Subjects with long standing infections
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method